The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

New research from Memorial Sloan Kettering Cancer Center (MSK) reports encouraging results for a new liposarcoma treatment; describes more potent CAR T cells that can be given at lower doses; relates ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the ...

Prognostic Models From Transcriptomic Signatures of the Tumor Microenvironment and Cell Cycle in Stage III Colon Cancer From PETACC-8 and IDEA-France Trials In this pilot study, we assessed the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Sarcoma is a rare and complex cancer that most people never ...

Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - January 13, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor ...

Purpose Sarcomas are cancers of connective tissue and account for approximately 10–15% of all cancer cases in children aged ≤16 years. Treatment often involves chemotherapy, surgery and radiotherapy.

Stanford-led study included over 2,100 Signatera samples from over 200 sarcoma patients, with overall sensitivity of 89% and specificity of 100% Leiomyosarcoma, the most common subtype in the cohort, ...

If approved, afami-cel will be the first engineered T-cell therapy for solid tumors and the first effective treatment option for synovial sarcoma in more than a decade Philadelphia, Pennsylvania and ...